Known since Hippocrates and of continuing public health importance, influenza remains a
major cause of morbidity and mortality worldwide, and large segments of the human …

Influenza virus infection causes seasonal epidemics and occasional pandemics, leading to
huge morbidity and mortality worldwide. Vaccination against influenza is needed annually …

Compared to intramuscular vaccines, nasally administered vaccines have the advantage of
inducing local mucosal immune responses that may block infection and interrupt …

Background Data on influenza community burden and transmission are important to plan
interventions especially in resource-limited settings. However, data are limited, particularly …

Abstract Objectives In recent years, Italy has been registering peaks in death rates,
particularly among the elderly during the winter season. Influenza epidemics have been …

The United Kingdom (UK) is in the third season of introducing universal paediatric influenza
vaccination with a quadrivalent live attenuated influenza vaccine (LAIV). The 2015/16 …

Background Many countries have recently expanded their childhood immunisation
programmes. Schools are an increasingly attractive setting for delivery of these new …

The effect of influenza vaccination (FluVac) on the risk of neurodegenerative diseases has
not been well evaluated in prospective populations. We aimed to assess the association …

Background After vaccination, vaccinees acquire some protection against infection and/or
disease. Vaccination, therefore, reduces the number of infections in the population. Due to …

Background In the UK, annual influenza vaccination is currently recommended for adults
aged 16–64 years who are in a clinical at-risk group. Despite recommendations, rates of …